Treatment failure among Sub-Sahara African children living with HIV: a systematic review and meta-analysis

Kliegman SG B, SHAH,TASKER,WILSON. Nelson Textbook of Pediatrics. 21st edition. Philadelphia: Elsevier, United States of America: 2020.

Cohen MS, Hellmann N, Levy JA, DeCock K, Lange J. The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. J Clin Investig. 2008;118(4):1244–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Organization WH. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: World Health Organization; 2016.

Google Scholar 

Iliff PJ, Piwoz EG, Tavengwa NV, Zunguza CD, Marinda ET, Nathoo KJ, et al. Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS. 2005;19(7):699–708.

Article  PubMed  Google Scholar 

Adetokunboh OO, Oluwasanu M. Eliminating mother-to-child transmission of the human immunodeficiency virus in sub-Saharan Africa: The journey so far and what remains to be done. J Infect Public Health. 2016;9(4):396–407.

Article  PubMed  Google Scholar 

Unaids G. HIV & AIDS Statistics—2019 Fact Sheet. Geneva: Switzerland; 2019.

Google Scholar 

Organization WH. Global status report on alcohol and health 2018: World Health Organization; 2019.

HIV/AIDS Strategic Plan 2015–2020 by the Federal Democratic Republic of Ethiopia Ministry of Health FHAPaCOAA, Ethiopia.

Unaids W. Global AIDS monitoring. Geneva: UNAIDS; 2017.

Google Scholar 

Judd A, Lodwick R, Noguera-Julian A, Gibb D, Butler K, Costagliola D, et al. Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. Higher rates of triple-class virological failure in perinatally HIV infected teenagers compared with heterosexually infected young adults in Europe. HIV MEDICINE. 2016.

Organization WH. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach: World Health Organization; 2016.

Levi J, Raymond A, Pozniak A, Vernazza P, Kohler P, Hill A. Can the UNAIDS 90–90-90 target be achieved? A systematic analysis of national HIV treatment cascades. BMJ Glob Health. 2016;1(2): e000010.

Article  PubMed  PubMed Central  Google Scholar 

Sidibé M, Loures L, Samb B. The UNAIDS 90–90–90 target: a clear choice for ending AIDS and for sustainable health and development. Journal of the International AIDS Society. 2016;19(1).

Organization WH. The global health sector strategy on HIV. 2014.

El-Khatib Z, Katzenstein D, Marrone G, Laher F, Mohapi L, Petzold M, et al. Adherence to drug-refill is a useful early warning indicator of virologic and immunologic failure among HIV patients on first-line ART in South Africa. PLoS ONE. 2011;6(3):e17518.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meyers T, Sawry S, Wong JY, Moultrie H, Pinillos F, Fairlie L, et al. Virologic failure among children taking lopinavir/ritonavir-containing first-line antiretroviral therapy in South Africa. Pediatr Infect Dis J. 2015;34(2):175.

Article  PubMed  PubMed Central  Google Scholar 

Davies M-A, Moultrie H, Eley B, Rabie H, Van Cutsem G, Giddy J, et al. Virologic failure and second-line antiretroviral therapy in children in South Africa-The IeDEA Southern Africa Collaboration. J Acquired Immun Deficiency Syndromes (1999). 2011;56(3):270.

Article  CAS  Google Scholar 

Muri L, Gamell A, Ntamatungiro AJ, Glass TR, Luwanda LB, Battegay M, et al. Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania: an emerging public health concern. AIDS (London, England). 2017;31(1):61.

Article  CAS  PubMed  Google Scholar 

Mgelea EM, Kisenge R, Aboud S. Detecting virological failure in HIV-infected Tanzanian children. S Afr Med J. 2014;104(10):696–9.

Article  CAS  PubMed  Google Scholar 

Nlend AEN, Lyeb S, Moyo STN, Motaze AN. Viral Monitoring and Prevalence of Viral Failure in HIV-1 Infected Children under First Line Antiretroviral Therapy during the First 60 Months of Treatment in Yaoundé, Cameroon: A Serial Cross Sectional Analysis. Open Journal of Pediatrics. 2016;6(1):69–74.

Article  Google Scholar 

Zoufaly A, Fillekes Q, Hammerl R, Nassimi N, Jochum J, Drexler JF, et al. Prevalence and determinants of virological failure in HIV-infected children on antiretroviral therapy in rural Cameroon: a cross-sectional study. Antivir Ther. 2013;18(5):681–90.

Article  CAS  PubMed  Google Scholar 

Orji M-L, Onyire NB, Ojukwu JO, Oyim-Elechi CO. The outcome of intervention, characteristics, and determinants of treatment failure in HIV-infected adolescents on first-line antiretroviral therapy at a tertiary health institution. South-east Nigeria Nigerian Journal of Medicine. 2021;30(5):586–91.

Google Scholar 

Boerma RS, Boender TS, Sigaloff KC, Rinke de Wit TF, Van Hensbroek MB, Ndembi N, et al. High levels of pre‐treatment HIV drug resistance and treatment failure in Nigerian children. J Int  AIDS Soc. 2016;19(1):21140.

Tadesse BT, Foster BA, Jerene D, Ruff A. Cohort profile: improving treatment of HIV-infected Ethiopian children through better detection of treatment failure in southern Ethiopia. BMJ Open. 2017;7(2):e013528.

Article  PubMed  PubMed Central  Google Scholar 

Haile GS, Berha AB. Predictors of treatment failure, time to switch and reasons for switching to second line antiretroviral therapy in HIV infected children receiving first line anti-retroviral therapy at a Tertiary Care Hospital in Ethiopia. BMC Pediatr. 2019;19:1–9.

Article  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88: 105906.

Article  PubMed  Google Scholar 

Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. bmj. 2021;372.

Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command to perform meta-analysis of binomial data. Archives of Public Health. 2014;72:1–10.

Article  Google Scholar 

Rücker G, Schwarzer G, Carpenter JR, Schumacher M. Undue reliance on I 2 in assessing heterogeneity may mislead. BMC Med Res Methodol. 2008;8:1–9.

Article  Google Scholar 

Borenstein M, Hedges LV, Higgins JP, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Research synthesis methods. 2010;1(2):97–111.

Article  PubMed  Google Scholar 

Bacha T, Tilahun B, Worku A. Predictors of treatment failure and time to detection and switching in HIV-infected Ethiopian children receiving first line anti-retroviral therapy. BMC Infect Dis. 2012;12(1):1–8.

Article  Google Scholar 

Sisay MM, Ayele TA, Gelaw YA, Tsegaye AT, Gelaye KA, Melak MF. Incidence and risk factors of first-line antiretroviral treatment failure among human immunodeficiency virus-infected children in Amhara regional state, Ethiopia: a retrospective follow-up study. BMJ Open. 2018;8(4):e019181.

Article  PubMed  PubMed Central  Google Scholar 

Yihun BA, Kibret GD, Leshargie CT. Incidence and predictors of treatment failure among children on first-line antiretroviral therapy in Amhara Region Referral Hospitals, northwest Ethiopia 2018: A retrospective study. PLoS ONE. 2019;14(5): e0215300.

Article  PubMed  PubMed Central  Google Scholar 

Getaneh Y, Yizengaw A, Likie A, Getahun M, Feleke A, Kidane E, et al. Rate and predictors of Treatment Failure among pediatric population taking Highly Active Antiretroviral Therapy in Ethiopia. medRxiv. 2019:19005538.

Wondifraw EB ea. Predictors of first-line antiretroviral treatment failure among children on antiretroviral therapy at the University of Gondar comprehensive specialised hospital, North-west,Ethiopia: a 14-year long-term follow up study. BMJ Open. 2022,12(12):e064354.

Yassin S, Gebretekle GB. Magnitude and predictors of antiretroviral treatment failure among HIV-infected children in Fiche and Kuyu hospitals, Oromia region, Ethiopia: a retrospective cohort study. Pharmacol Res Perspect. 2017;5(1): e00296.

Article  PubMed  PubMed Central  Google Scholar 

Getawa S, Fentahun A, Adane T, Melku M. Antiretroviral treatment failure and associated factors among HIV-infected children on antiretroviral therapy: a retrospective study. HIV/AIDS-Research and Palliative Care. 2021;(13):229–37.

Workneh N, Girma T, Woldie M. Immunologic and clinical outcomes of children on HAART: a Retrospective cohort analysis at Jimma University specialized hospital. Ethiop J Health Sci. 2009;19(2):75–82

Gelaw B, Mulatu G, Tesfa G, Marew C, Chekole B, Alebel A. Magnitude and associated factors of virological failure among children on ART in Bahir Dar Town public health facilities, Northwest Ethiopia: a facility based cross-sectional study. Ital J Pediatr. 2021;47:1–9.

Article  Google Scholar 

Zeleke A. Prevalence of antiretroviral treatment failure and associated factors in HIV infected children on antiretroviral therapy at Gondar University Hospital, retrospective cohort study. International Journal of Medicine and Medical Sciences. 2016;8(11):125–32.

Article  Google Scholar 

Bitwale NZ, Mnzava DP, Kimaro FD, Jacob T, Mpondo BC, Jumanne S. Prevalence and factors associated with virological treatment failure among children and adolescents on antiretroviral therapy attending HIV/AIDS care and treatment clinics in dodoma municipality, central tanzania. Journal of the Pediatric Infectious Diseases Society. 2021;10(2):131–40.

Article  CAS  PubMed  Google Scholar 

Emmett SD, Cunningham CK, Mmbaga BT, Kinabo GD, Schimana W, Swai ME, et al. Predicting virologic failure among HIV-1-infected children receiving antiretroviral therapy in Tanzania: a cross-sectional study. J Acq Immun Deficiency Synd (1999). 2010;54(4):368.

Article  Google Scholar 

Tagnouokam-Ngoupo PA, Penda IC, Tchatchueng Mbougua JB, Tetang Ndiang S, Yuya Septoh F, Kenne A, et al. Virological failure and antiretroviral resistance among HIV-infected children after five years follow-up in the ANRS 12225-PEDIACAM cohort in Cameroon. PLoS ONE. 2021;16(3): e0248642.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sebunya R, Musiime V, Kitaka SB, Ndeezi G. Incidence and risk factors for first line anti retroviral treatment failure among Ugandan children attending an urban HIV clinic. AIDS Res Ther. 2013;10:1–10.

Article  Google Scholar 

Costenaro P, Penazzato M, Lundin R, Rossi G, Massavon W, Patel D, et al. Predictors of treatment failure in HIV-positive children receiving combination antiretroviral therapy: cohort data from Mozambique and Uganda. Journal of the Pediatric Infectious Diseases Society. 2015;4(1):39–48.

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif